|
|
| (One intermediate revision by one other user not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Bivalirudin#Patient Counseling Information]] |
| {{Bivalirudin}}
| |
| {{CMG}} {{AE}}{{JH}}
| |
|
| |
|
| ==Patient Counseling Information==
| | [[Category: Cardiovascular Drugs]] |
| | | [[Category: Drug]] |
| Advise patients to watch carefully for any signs of bleeding or bruising and to report these to their health care provider when they occur.
| | [[Category: Anticoagulants]] |
| | |
| Advise patients to discuss with their health care provider their use of any other medications, including over-the-counter medications or herbal products, prior to Angiomax use. Examples of other medications that should not be taken with Angiomax are warfarin and heparin.
| |
| | |
| Marketed by:
| |
| The Medicines Company
| |
| Parsippany, NJ 07054
| |
| For information call: (800) 264-4662
| |
| | |
| U.S. Patents 5,196,404; 7,598,343; 7,582,727
| |
| | |
| Hemochron® is a registered trademark of International Technidyne Corporation, Edison, NJ.<ref>{{Cite web | last = | first = | title = ANGIOMAX (BIVALIRUDIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THE MEDICINES COMPANY] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=911cd48f-01ea-4dec-b30c-95e7e0ea9d2a | publisher = | date = | accessdate = 10 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| | |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]] | |
| [[Category:Drugs]] | |